BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 23174190)

  • 21. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
    Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoplasmic reticulum stress signaling in mammalian oocytes and embryos: life in balance.
    Latham KE
    Int Rev Cell Mol Biol; 2015; 316():227-65. PubMed ID: 25805126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-21 and multiple myeloma: small molecule and big function.
    Ma J; Liu S; Wang Y
    Med Oncol; 2014 Aug; 31(8):94. PubMed ID: 24981236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity.
    Quotti Tubi L; Gurrieri C; Brancalion A; Bonaldi L; Bertorelle R; Manni S; Pavan L; Lessi F; Zambello R; Trentin L; Adami F; Ruzzene M; Pinna LA; Semenzato G; Piazza F
    J Hematol Oncol; 2013 Oct; 6():78. PubMed ID: 24283803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
    Manni S; Brancalion A; Tubi LQ; Colpo A; Pavan L; Cabrelle A; Ave E; Zaffino F; Di Maira G; Ruzzene M; Adami F; Zambello R; Pitari MR; Tassone P; Pinna LA; Gurrieri C; Semenzato G; Piazza F
    Clin Cancer Res; 2012 Apr; 18(7):1888-900. PubMed ID: 22351691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supervision of multiple signaling protein kinases by the CK2-Cdc37 couple, a possible novel cancer therapeutic target.
    Miyata Y; Nishida E
    Ann N Y Acad Sci; 2004 Dec; 1030():150-7. PubMed ID: 15659792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel players in multiple myeloma pathogenesis: role of protein kinases CK2 and GSK3.
    Piazza F; Manni S; Semenzato G
    Leuk Res; 2013 Feb; 37(2):221-7. PubMed ID: 23174190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways.
    Piazza F; Manni S; Ruzzene M; Pinna LA; Gurrieri C; Semenzato G
    Leukemia; 2012 Jun; 26(6):1174-9. PubMed ID: 22289987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting CK2-driven non-oncogene addiction in B-cell tumors.
    Mandato E; Manni S; Zaffino F; Semenzato G; Piazza F
    Oncogene; 2016 Nov; 35(47):6045-6052. PubMed ID: 27041560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of protein kinases CK1α and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways.
    Manni S; Carrino M; Piazza F
    J Hematol Oncol; 2017 Oct; 10(1):157. PubMed ID: 28969692
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.